Usana Health Sciences (USNA) Cash from Investing Activities (2016 - 2026)
Usana Health Sciences has reported Cash from Investing Activities over the past 16 years, most recently at -$2.6 million for Q2 2026.
- Quarterly Cash from Investing Activities rose 32.98% to -$2.6 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was -$8.8 million through Apr 2026, up 95.84% year-over-year, with the annual reading at -$10.1 million for FY2026, 95.25% up from the prior year.
- Cash from Investing Activities was -$2.6 million for Q2 2026 at Usana Health Sciences, down from $1.1 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $1.1 million in Q1 2026 and troughed at -$205.1 million in Q4 2024.
- The 5-year median for Cash from Investing Activities is -$3.2 million (2022), against an average of -$14.0 million.
- Year-over-year, Cash from Investing Activities soared 104.81% in 2023 and then crashed 2701.67% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$3.3 million in 2022, then plummeted by 123.1% to -$7.3 million in 2023, then crashed by 2701.67% to -$205.1 million in 2024, then surged by 98.44% to -$3.2 million in 2025, then grew by 18.79% to -$2.6 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Cash from Investing Activities are -$2.6 million (Q2 2026), $1.1 million (Q1 2026), and -$3.2 million (Q3 2025).